pfizer

Nearly 200 vaccine candidates against the coronavirus are being studied around the world. 198, precisely, counted the World Health Organization, ten of which entered the third phase of testing, the one before marketing. This Monday, Pfizer hit the headlines by announcing convincing results, but where are the others?

Pfizer will likely have millions of coronavirus vaccine doses ready by the end of 2020 — and the company’s CEO is willing to be one of the first to take it. The Manhattan-based drugmaker

The coronavirus vaccine developed by Pfizer and BioNTech is more than 90 percent effective, the companies said Monday in a major milestone for the fight against the deadly global pandemic. The

Bill Gates says Pfizer has the best chance of seeking emergency approval for a coronavirus vaccine by next month even though he thinks such an aggressive timeline is unlikely. “The only vaccine that if everything went perfectly, might seek the emergency use license by the end of October, would be Pfizer,” the billionaire tech tycoon-turned-philanthropist …

Pharmaceutical giant Pfizer will likely know by the end of next month if its coronavirus vaccine is effective, CEO Albert Bourla said. There’s a “more than 60 percent” chance that the drugmaker’s clinical research will produce results by the end of October showing whether or not the shot works, Bourla said in a Sunday TV …

Nine drugmakers pledged Tuesday to make safety their top priority as they race to develop a vaccine for the deadly coronavirus — vowing they would not seek emergency authorization before large-scale Phase 3 clinical trials are completed. The biopharma firms said in a joint statement that they would follow “high ethical standards and sound scientific …

The feds placed a $2 billion order for 100 million doses of Pfizer’s potential coronavirus vaccine under the Trump administration’s push to have a shot ready by next year. Americans would receive Pfizer’s shots for free under the deal announced Wednesday — assuming the vaccine it’s developing with the German biotech firm BioNTech wins federal …

Shares of Pfizer fell nearly 7 percent on Monday after an independent data monitoring committee determined the drugmaker’s breast cancer treatment was unlikely to meet the main goal of a late-stage study. The treatment, Ibrance, was being tested along with the standard of care for early breast cancer in men and women, against standard of …

Drugmaker Pfizer said Thursday that it is working on a promising treatment for coronavirus, as well as vaccine. The drugmaker said preclinical studies showed that an unspecified compound that was originally used to treat SARS — a different coronavirus — has shown potential in battling the dangerous illness. Pfizer research chief Mikael Dolsten said the …